Nifty
Sensex
:
:
10349.70
33537.52
50.95 (0.49%)
177.62 (0.53%)

Pharmaceuticals & Drugs

Rating :
32/99

BSE: 532649 | NSE: NECLIFE

30.80
0.10 (0.33%)
21-Nov-2017 | 11:19AM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  • 30.95
  • 31.25
  • 30.55
  • 30.70
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  • 141823
  • 43.68
  • 43.65
  • 23.80

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 687.36
  • 12.28
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,552.28
  • 0.16%
  • 0.66

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 55.8%
  • 19.99%
  • 17.99%
  • FII
  • DII
  • Others
  • 0.08%
  • 0.5%
  • 5.64%

Chart

Price | P:E | P:BV | EV:EBITDA

Quarterly Results

Standalone Figures in Rs. Crores

Description
Jun 17
Jun 16
Var%
Mar 17
Mar 16
Var%
Dec 16
Dec 15
Var%
Sep 16
Sep 15
Var%
Net Sales
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBITDA
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBIDTM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Other Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PBT
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PATM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
EPS
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Net Sales
1,643.70
1,675.69
1,643.64
1,638.31
1,626.25
1,313.11
1,062.06
845.80
727.97
735.95
Net Sales Growth
-1.91%
1.95%
0.33%
0.74%
23.85%
23.64%
25.57%
16.19%
-1.08%
 
Cost Of Goods Sold
1,154.31
1,174.12
1,141.33
1,154.68
1,142.12
906.71
711.07
544.31
485.98
534.56
Gross Profit
489.39
501.57
502.31
483.63
484.13
406.40
350.99
301.49
241.98
201.39
GP Margin
29.77%
29.93%
30.56%
29.52%
29.77%
30.95%
33.05%
35.65%
33.24%
27.36%
Total Expenditure
1,419.28
1,436.94
1,376.73
1,350.44
1,336.10
1,064.59
834.89
650.85
590.13
611.20
Power & Fuel Cost
75.44
87.89
79.60
66.10
60.94
41.89
33.95
28.92
27.60
23.86
% Of Sales
4.59%
5.25%
4.84%
4.03%
3.75%
3.19%
3.20%
3.42%
3.79%
3.24%
Employee Cost
75.54
78.38
58.93
47.97
45.64
43.94
33.79
28.96
26.09
18.16
% Of Sales
4.60%
4.68%
3.59%
2.93%
2.81%
3.35%
3.18%
3.42%
3.58%
2.47%
Manufacturing Exp.
53.32
39.56
37.05
33.57
34.04
29.74
23.92
12.73
10.43
7.09
% Of Sales
3.24%
2.36%
2.25%
2.05%
2.09%
2.26%
2.25%
1.51%
1.43%
0.96%
General & Admin Exp.
20.07
20.36
21.60
22.03
18.43
17.17
13.13
17.72
17.01
13.73
% Of Sales
1.22%
1.22%
1.31%
1.34%
1.13%
1.31%
1.24%
2.10%
2.34%
1.87%
Selling & Distn. Exp.
39.00
35.24
35.25
24.71
29.84
18.48
14.84
14.41
15.51
11.56
% Of Sales
2.37%
2.10%
2.14%
1.51%
1.83%
1.41%
1.40%
1.70%
2.13%
1.57%
Miscellaneous Exp.
1.60
1.41
2.97
1.38
5.09
6.66
4.19
3.79
7.51
11.56
% Of Sales
0.10%
0.08%
0.18%
0.08%
0.31%
0.51%
0.39%
0.45%
1.03%
0.30%
EBITDA
224.42
238.75
266.91
287.87
290.15
248.52
227.17
194.95
137.84
124.75
EBITDA Margin
13.65%
14.25%
16.24%
17.57%
17.84%
18.93%
21.39%
23.05%
18.93%
16.95%
Other Income
22.66
5.78
20.00
12.53
16.04
12.89
13.46
19.40
6.24
4.86
Interest
117.41
123.31
125.59
137.99
115.49
115.25
74.09
60.30
49.62
27.37
Depreciation
62.25
57.39
76.56
84.19
75.96
60.73
46.10
38.75
30.31
19.48
PBT
67.42
63.83
84.75
78.23
114.75
85.43
120.44
115.30
64.16
82.75
Tax
12.08
9.59
18.49
16.14
29.01
12.22
16.24
23.01
11.19
8.01
Tax Rate
17.92%
15.02%
21.82%
20.63%
25.28%
14.30%
13.48%
19.96%
17.44%
9.68%
PAT
55.34
54.24
66.26
62.09
85.74
73.22
104.20
92.29
52.97
74.74
PAT before Minority Interest
55.34
54.24
66.26
62.09
85.74
73.22
104.20
92.29
52.97
74.74
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
3.37%
3.24%
4.03%
3.79%
5.27%
5.58%
9.81%
10.91%
7.28%
10.16%
PAT Growth
2.03%
-18.14%
6.72%
-27.58%
17.10%
-29.73%
12.90%
74.23%
-29.13%
 
Unadjusted EPS
2.47
2.42
2.95
2.77
3.82
3.26
4.65
5.83
3.47
49.09

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Shareholder's Funds
1,006.68
954.08
957.95
927.06
867.60
784.46
721.13
620.65
303.35
284.01
Share Capital
22.43
22.43
22.43
22.43
22.43
22.43
22.43
22.43
15.23
15.23
Total Reserves
984.25
931.65
935.52
904.64
845.17
762.04
698.71
598.22
288.13
268.79
Non-Current Liabilities
295.58
362.30
396.92
340.94
361.54
432.02
288.67
651.08
744.53
515.21
Secured Loans
161.20
243.44
264.36
222.59
260.48
362.93
233.60
451.02
502.23
342.40
Unsecured Loans
2.60
1.96
1.17
0.75
0.48
0.69
0.74
149.88
202.11
142.44
Long Term Provisions
8.49
6.91
6.01
4.90
3.79
3.43
2.41
0.00
0.00
0.00
Current Liabilities
1,278.66
1,239.95
1,155.60
1,126.07
1,044.90
904.38
802.79
208.76
237.72
149.30
Trade Payables
528.10
496.78
455.58
440.06
382.52
194.49
139.83
134.52
175.33
106.82
Other Current Liabilities
106.88
107.95
90.50
86.72
131.28
129.87
245.93
9.28
8.36
3.82
Short Term Borrowings
630.34
627.24
595.30
579.84
509.11
565.21
330.01
0.00
0.00
0.00
Short Term Provisions
13.34
7.98
14.22
19.45
22.00
14.81
87.02
64.96
54.03
38.66
Total Liabilities
2,580.92
2,556.33
2,510.47
2,394.07
2,274.04
2,120.86
1,812.59
1,480.49
1,285.60
948.52
Net Block
881.24
905.58
933.73
947.54
913.84
857.87
736.26
627.26
525.94
363.40
Gross Block
1,420.94
1,383.66
1,451.42
1,341.15
1,223.31
1,091.46
909.26
754.17
614.44
422.77
Accumulated Depreciation
539.70
478.08
517.69
393.61
309.47
233.59
173.00
126.91
88.50
59.37
Non Current Assets
1,082.05
1,091.92
1,105.54
1,156.72
1,122.94
1,071.18
868.56
682.51
598.88
422.88
Capital Work in Progress
102.11
99.35
91.31
122.26
138.57
150.13
82.42
55.51
74.03
57.50
Non Current Investment
0.27
0.27
0.15
0.05
0.05
0.05
0.05
-0.26
-1.09
1.98
Long Term Loans & Adv.
93.90
82.24
80.34
86.87
70.48
63.12
49.84
0.00
0.00
0.00
Other Non Current Assets
4.53
4.47
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
1,498.87
1,464.42
1,369.02
1,237.34
1,151.08
1,049.67
944.00
797.94
686.39
525.05
Current Investments
0.41
0.52
0.44
0.31
0.32
0.14
5.33
21.32
2.07
0.00
Inventories
854.65
836.71
790.98
758.43
676.00
591.42
470.88
396.35
349.62
199.69
Sundry Debtors
502.74
491.45
446.50
376.65
349.39
304.49
311.13
222.46
167.26
159.52
Cash & Bank
13.18
36.65
33.38
9.98
6.24
25.93
32.58
34.79
34.47
26.03
Other Current Assets
127.89
31.54
13.12
22.95
119.13
127.70
124.08
123.02
132.96
139.81
Short Term Loans & Adv.
74.01
67.55
84.61
69.02
86.84
105.05
102.03
96.55
100.81
139.81
Net Current Assets
220.21
224.47
213.42
111.27
106.18
145.29
141.21
589.18
448.67
375.76
Total Assets
2,580.92
2,556.34
2,510.47
2,394.07
2,274.04
2,120.87
1,812.59
1,480.49
1,285.61
948.52

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Cash From Operating Activity
198.76
168.82
144.41
254.87
360.83
164.96
43.81
55.31
131.71
149.27
PBT
67.44
64.74
84.75
78.22
114.75
85.43
120.44
115.30
64.16
82.75
Adjustment
158.81
174.16
185.24
212.94
179.63
156.84
122.10
84.05
77.34
42.25
Changes in Working Capital
-20.33
-61.52
-119.29
-16.31
68.28
-64.33
-186.05
-131.53
0.52
62.96
Cash after chg. in Working capital
205.93
177.38
150.70
274.85
362.66
177.94
56.48
67.81
142.03
187.96
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-7.17
-8.56
-6.29
-19.98
-1.83
-12.98
-12.67
-12.50
-10.31
-11.32
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-18.11
-76.88
-59.53
-89.99
-98.95
-233.56
-168.65
-145.57
-181.55
-119.77
Net Fixed Assets
-40.04
59.72
-79.32
-101.53
-120.29
-249.91
-182.00
-121.21
-210.57
-134.59
Net Investments
0.11
-0.53
-0.23
0.01
-0.18
5.19
20.32
-20.09
1.00
-0.24
Others
21.82
-136.07
20.02
11.53
21.52
11.16
-6.97
-4.27
28.02
15.06
Cash from Financing Activity
-204.12
-88.68
-61.47
-161.14
-281.56
61.95
122.63
90.57
58.28
-39.45
Net Cash Inflow / Outflow
-23.47
3.27
23.40
3.74
-19.68
-6.65
-2.21
0.32
8.44
-9.95
Opening Cash & Equivalents
36.65
33.38
9.98
6.24
25.93
32.58
34.79
34.47
26.03
35.98
Closing Cash & Equivalent
13.18
36.65
33.38
9.98
6.24
25.93
32.58
34.79
34.47
26.03

Financial Ratios

Consolidated /

Standalone
Description
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Book Value (Rs.)
44.89
42.54
41.11
41.34
38.69
34.98
32.15
27.67
19.90
18.61
ROA
2.15%
2.14%
2.70%
2.66%
3.90%
3.72%
6.33%
6.67%
4.74%
8.66%
ROE
5.64%
5.78%
7.17%
6.92%
10.38%
9.73%
15.53%
19.98%
18.07%
29.60%
ROCE
9.73%
9.95%
11.58%
12.24%
12.88%
12.00%
14.21%
15.76%
12.82%
15.60%
Fixed Asset Turnover
1.24
1.26
1.25
1.33
1.45
1.35
1.35
1.29
1.50
2.39
Receivable days
104.04
95.49
85.98
77.54
71.26
83.13
86.76
80.29
76.46
64.70
Inventory Days
176.99
165.71
161.85
153.20
138.12
143.44
141.01
153.69
128.53
93.33
Payable days
128.03
119.13
113.39
105.76
76.22
54.56
55.61
85.15
84.62
48.61
Cash Conversion Cycle
153.00
142.07
134.44
124.98
133.15
172.00
172.16
148.82
120.36
109.42
Total Debt/Equity
0.87
1.01
1.00
0.93
1.01
1.33
1.10
0.97
2.32
1.71
Interest Cover
1.57
1.52
1.67
1.57
1.99
1.74
2.63
2.91
2.29
4.02

Top Investors:

News Update:


  • Nectar Lifesciences - Quarterly Results
    11th Nov 2017, 12:58 PM

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.